/

Global Cord Blood Corporation

CO UN

CO UNGlobal Cord Blood Corporation

NYSE

1.17

USD

+0.02

(+1.74%)

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

Next Earnings

October 30

Ex-Dividend Date

July 31

Held by Insiders

61.55%

Held by Institutions

22.17%

Short % of Float

0.80%

YTD Yield

-60.87%

3Y Yield

-70.23%

5Y Yield

-80.40%

Capital Structure

FRC

•

in mil. unless spec.

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

Shares Outstanding

Market Capitalization

Working Capital

FRC

•

in mil. unless spec.

Total Current Assets

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

- -

Net Income, GAAP

- -

Free Cash Flow

- -

Total Cash Common Dividend

- -

Total Equity

- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

-Infinity

- -

-Infinity

- -

-Infinity

- -

Company Description

CEO: Ms. Ting Zheng
Full Time Employees: 1,202
Sector: Healthcare
Industry: Diagnostics & Research
Address: Bank of China Tower Central Hong Kong
Website: www.globalcordbloodcorp.com
Business: Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.